Background—It is well established that hypertensive patients with left ventricular (LV)
hypertrophy have impaired diastolic filling. However, the impact of antihypertensive …

Background—We have shown that hypertensive patients with left ventricular (LV)
hypertrophy have decreased LV midwall mechanics, but the effect of antihypertensive …

Patients with hypertension and left ventricular (LV) hypertrophy commonly have impaired
diastolic filling. However, it remains unknown whether changes in LV diastolic filling …

Abnormal left ventricular (LV) filling may exist in early stages of hypertension. Whether this
finding is related to LV hypertrophy is currently controversial. This study was undertaken to …

The effect of enalapril on left ventricular (LV) morphology and function was studied in 12
hypertensive patients. The subjects were evaluated after 2 weeks of placebo and after 4 …

Background—An echocardiographic substudy of the Losartan Intervention for Endpoint
Reduction in Hypertension (LIFE) trial was designed to test the ability of losartan to reduce …

This study was undertaken to determine the prevalence and significance of diastolic left
ventricular (LV) dysfunction in mild to moderate systemic hypertension. Rest and exercise …

Background and hypothesis: Systemic hypertension is the leading cause of left ventricular
(LV) hypertrophy. The present study aimed to investigate the mechanism of left atrial (LA) …

Abnormalities of left ventricular (LV) diastolic filling and stress-corrected midwall shortening
(MWS) have been described in hypertensive patients with normal ejection fraction (EF) …

Left ventricular hypertrophy (LVH) is an independent risk indicator of cardiovascular
disease. Obtaining reversal of hypertension-induced cardiac hypertrophy seems to be a …